Ernexa Therapeutics Inc. (ERNA) Gross margin 2024–2025
Ernexa Therapeutics Inc. (ERNA) gross margin by fiscal year — reported gross profit divided by reported revenue.
83.5%FY2025 · since FY2024: -247.1% → 83.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 83.5% | +330.6 pp |
| FY2024 | -247.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ERNA financial trends
ERNA RevenueERNA Net incomeERNA Net marginERNA Gross profitERNA Operating incomeERNA Operating marginERNA Operating cash flowERNA Free cash flowERNA Capital expendituresERNA Return on equityERNA Stock buybacksERNA Dividends paidERNA Total assetsERNA Total liabilitiesERNA Shareholders’ equityERNA overview →